What is the Medicare Current Procedural Terminology (CPT) code for a women's health exam for a patient 21 years or older?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medicare CPT Codes for Women's Health Exam (Age 21+)

For a comprehensive women's health exam in Medicare patients aged 21 or older, use CPT code G0101 (cervical/vaginal cancer screening including pelvic and clinical breast examination) when performed as a preventive service, or standard office visit codes (99201-99205 for new patients, 99211-99215 for established patients) when performed as part of an evaluation and management service.

Preventive Service Coding

G0101 - Cervical or Vaginal Cancer Screening

  • This Medicare-specific code covers the pelvic examination and clinical breast examination when performed as part of preventive screening 1
  • Includes inspection for suspicious lesions or signs of sexually transmitted diseases during the genital examination 1
  • Can be billed once every 24 months for average-risk women, or annually for high-risk women 1

Q0091 - Pap Smear Collection

  • Use this code separately for obtaining the cervical cytology specimen 1
  • For women aged 21-65 years, screening should occur every 3 years with conventional or liquid-based Pap tests 1
  • For women aged 30-65 years, screening every 5 years with combined HPV and Pap testing is preferred, or every 3 years with Pap test alone is acceptable 1

Evaluation and Management Coding Alternative

Office Visit Codes (99201-99215)

  • When the women's health exam is performed as part of a problem-oriented visit rather than pure preventive care, use standard E/M codes 2
  • Code selection requires meeting 2 of 3 medical decision-making (MDM) elements: problems addressed, data reviewed, and risk of complications 2
  • Time-based coding is an alternative if counseling dominates more than 50% of the visit 2, 3

Component Services to Document

Clinical Breast Examination

  • For women in their 20s and 30s, perform every 3 years as part of periodic health examination 1, 4
  • For women aged 40 and older, perform annually, preferably prior to mammography 1, 4
  • ACOG recommends annual examination for all women aged >19 years 1

Cervical Cancer Screening

  • Begin at age 21 years regardless of sexual activity onset 1
  • Never screen women under age 21 years (Grade D recommendation) 1
  • Women over age 65 with 3 consecutive normal Pap tests or 2 consecutive negative HPV and Pap tests within the last 10 years may discontinue screening 1, 4
  • Women with total hysterectomy for benign conditions should stop screening 1, 4

Genital Examination

  • Must accompany cervical cancer screening to inspect for suspicious lesions or signs indicating undiagnosed STDs 1
  • Document inspection of external genitalia, vaginal walls, and cervix 1

Common Pitfalls to Avoid

  • Do not bill G0101 and a standard office visit code on the same date unless the office visit addresses a separate, significant problem requiring additional evaluation beyond the preventive service 2, 5
  • Do not screen annually with any cervical cancer screening method - this is explicitly not recommended and will result in claim denials 1
  • Do not perform Pap smears on women under age 21 - this is a Grade D recommendation (harm outweighs benefit) 1
  • Do not delay contraceptive initiation for cervical cytology results 1
  • Do not use outdated annual screening intervals - cervical cancer screening frequency has changed from annual to every 3-5 years depending on age and test type 1

Additional Screening Considerations

Risk Assessment

  • Document family history of breast and ovarian cancers in first-degree and second-degree relatives on both maternal and paternal sides going back 3 generations 1
  • Women with identified BRCA mutation risk factors should be referred for genetic counseling 1

Mammography Referral

  • Annual mammography should begin at age 40 years per ACS guidelines 1, 4
  • USPSTF recommends biennial screening for women aged 50-74 years 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluation and Management Coding Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cancer Screening and Preventive Care Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.